AlphAIalphai — Financial news for AI agents
yahoo.comAUG 63 min read$DOCS

Doximity’s (NYSE:DOCS) Q2 CY2026: Beats On Revenue

Doximity (NYSE:DOCS) reported Q2 CY2026 revenue of $156.6 million, above analyst estimates of $151.3 million. Adjusted EPS was $0.29 versus $0.30 expected. Adjusted EBITDA was $74.77 million, above estimates. The company raised full-year revenue guidance to $676 million at the midpoint but set full-year EBITDA guidance of $319 million, below expectations.

Original reporting
yahoo.com
Published Aug 6, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Doximity’s (NYSE:DOCS) Q2 CY2026: Beats On Revenue — source image
Source · yahoo.com
Decision brief

The 30-second read

$DOCSNeutralMed
01

Why it matters

Revenue and adjusted EBITDA beat expectations and revenue guidance was slightly raised, but adjusted EPS missed and full-year EBITDA guidance is below consensus. Operating margin and free cash flow margin both declined versus prior periods.

02

Market read

Traders will likely reprice DOCS on the mix of beats (revenue, EBITDA) versus misses (adjusted EPS, full-year EBITDA guidance) and the noted margin/FCF deterioration.

03

What to watch

Margin compression and free cash flow deterioration are flagged, but the article does not explain drivers, so traders may need follow-up detail before extrapolating a structural slowdown.

Relevance 7/10Novelty 7/10Timing: post-market earnings/guidance update for DOCS

Background

The article summarizes Doximity’s Q2 CY2026 results versus analyst estimates and updates full-year guidance.

Company-level read

Ticker impact

$DOCSNeutralMedium confidence
Context

Doximity reported Q2 revenue of $156.6M vs $151.3M estimates, slightly lifted full-year revenue guidance, but missed adjusted EPS and EBITDA guidance.

Expected impact

Near-term volatility likely, with upside support from revenue/EBITDA beats offset by weaker EPS and full-year EBITDA guidance.

Evidence & confidence

The article provides multiple directional signals: revenue beat and raised revenue guidance are positive, while adjusted EPS miss and lower-than-estimated EBITDA guidance plus margin and FCF deterioration are negative.

Market effects

Sector

Limited direct read-through beyond digital health and communications platforms, since the piece is company-specific.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The raised full-year revenue midpoint and strong EBITDA beat could outweigh the EBITDA guidance miss if investors focus on operating leverage recovery.

Key entities

  • public_company
    Doximity

    NYSE-listed provider of professional networking and communications tools; reported Q2 results and updated full-year guidance.

Read at source← All news

Related articles

AUG 6
$TEAMMed

After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT

After-hours movers followed a day of lower stocks as oil prices and Treasury yields rose ahead of the jobs report. Atlassian (TEAM) rose 23% on a fiscal Q4 EPS beat and 2027 revenue guidance. Cloudflare (NET), Twilio (TWLO), and Doximity (DOCS) also gained. DoubleVerify (DV) jumped on a Nielsen all-cash deal. The Trade Desk (TTD) fell 23% on a revenue miss and weak guidance; Airbnb (ABNB) rose 9% and Rocket Companies (RKT) slid 10%.

investing.com6 min
AUG 6
$DOCSMed

Doximity, Inc. (DOCS): Results of Operations and Financial Condition

Doximity, Inc. (DOCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 doximity-2026630xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fiscal 2027 First Quarter Financial Results Total revenues of $156.6 million, up 7% year-over-year Net income of $24.3 million, margin of 16% Adjusted EBITDA of $74.8 million, margin of 48% SAN

SEC EDGAR 8-K6 min
JUL 15
$DOCSMed

UK’s Dr Martens backs annual outlook on US wholesale demand By Reuters

Reuters reports Dr Martens maintained its fiscal 2027 outlook, citing wholesale demand in the US. The company said trading has matched expectations since April, with Japan and South Korea performing well and Europe in line despite weak consumer conditions. In May it reported EMEA revenue decline tied to Iran-war fallout. Consensus expects adjusted pretax profit of £68m. Shares were up early.

investing.com3 min
AUG 6
$WPPMedAI 8/10

WPP Stock Soars 25% as Turnaround Finally Gains Traction

WPP reported Q2 results that were still weak but improved versus Q1, with like-for-like revenue less pass-through costs down 2.8% versus a 6.7% decline in Q1. First-half revenue less pass-through costs totaled $4.75 billion. First-half headline operating margin rose to 8.4% and adjusted net debt fell to $2.94 billion. WPP shares rose about 24.7% in U.S. trading.

yahoo.com4 min
AUG 6
$RDWMed

Why Redwire Stock Soared After Earnings

Redwire Corp. (RDW) shares rose about 11% after its Q2 results. The company reported a smaller-than-expected loss of $0.09 per share versus an expected $0.16, on revenue of $117 million versus $107.9 million. Redwire cited record revenue, 27.8% gross margin, and $542.1 million backlog, and forecast $450 million to $500 million sales for 2024.

fool.com3 min